Grown Rogue International (GRUSF) Operating Income (2009 - 2026)
Grown Rogue International (GRUSF) posted quarterly Operating Income of $99655.0 for Q1 2026, up 114.05% year-over-year from $46557.4 in Q1 2025, and down 100.0% quarter-over-quarter from $1434.9 billion in Q4 2025.
Grown Rogue International (GRUSF) Operating Income (2009 - 2026) Analysis & Trends
Grown Rogue International's Operating Income history runs 15 years deep, the most recent figure standing at $99655.0 for Q1 2026.
- In Q1 2026, Operating Income rose 114.05% year-over-year to $99655.0; the TTM figure through Mar 2026 stood at -$872890198.8 billion (down 546137675034861.25% YoY), while the FY2025 annual figure was -$593487.0, down 1089.44% from the prior year.
- Operating Income for Q1 2026 stood at $99655.0, down from $1434.9 billion in the prior quarter.
- The five-year high for Operating Income was $1434.9 billion in Q4 2025, with the low at -$872892000.0 billion in Q2 2025.
- The 5-year median for Operating Income is $646805.0 (2023), against an average of -$58192679.9 billion.
- Peak annual rise in Operating Income reached 2392297594.27% in 2025, while the deepest fall reached 935860437431563.9% in 2025.
- Grown Rogue International's Operating Income stood at $486613.0 in 2022, then declined by 12.42% to $426154.0 in 2023, then tumbled by 85.93% to $59980.0 in 2024, then jumped by 2392297594.27% to $1434.9 billion in 2025, then plunged by 100.0% to $99655.0 in 2026.
- Business Quant data shows GRUSF's Operating Income at $99655.0 in Q1 2026, $1434.9 billion in Q4 2025, and $366.3 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Grown Rogue International | 113.47 Mn | 101.93 Mn | 5.37 Mn | 836,656.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 836,656.00 |
| Mar 31, 2026 | 99,655.00 |
| Dec 31, 2025 | 1,434.90 Bn |
| Sep 30, 2025 | 366.34 Bn |
| Jun 30, 2025 | -872,892,000.00 Bn |
| Mar 31, 2025 | -709,401.00 |
| Dec 31, 2024 | 59,979.97 |
| Sep 30, 2024 | 715,979.13 |
| Jun 30, 2024 | 93,271.60 |
| Mar 31, 2024 | 927,094.00 |
| Dec 31, 2023 | 426,154.00 |
| Oct 31, 2023 | 4.47 Mn |
| Jul 31, 2023 | 2.24 Mn |
| Apr 30, 2023 | 826,790.00 |
| Jan 31, 2023 | 646,805.00 |
| Jan 31, 2022 | 486,613.00 |
| Oct 31, 2021 | 1.52 Mn |
| Jul 31, 2021 | 715,532.00 |
| Apr 30, 2021 | -622,950.00 |
| Jan 31, 2021 | 987,066.00 |